Benitec Biopharma's market cap is currently $391.66M. The company's EPS TTM is $0; its P/E ratio is ―; Benitec Biopharma is scheduled to report earnings on September 22, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
